Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday morning, amid a frenzied rush to match booming consumer demand for its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback